Naples Planned Parenthood Abortion Emergency?
This past May, a patient was rushed to a nearby Naples hospital after having a “procedure” performed at the Collier County Planned Parenthood. Transported via ambulance, little information was given about the patient’s condition. Cherie Wilson-Watson, who is a spokesperson for Emergency Medical Services in Collier County, stated that, “We received a medical call and transported someone to the hospital for evaluation.”
Coincidentally, the incident took place on May 24, 2010, a Monday, the only day the clinic performs abortion. During the time of the medical emergency, abortion opponents were protesting on a nearby sidewalk.
Because of healthcare privacy laws in the United States, Char Wendel, President and C.E.O. of Planned Parenthood declined to release any information, saying she could not give out any details on whether the ambulance call was in fact related to a botched abortion. She did go on later to state that “We are a medical facility and we respond to emergencies.”
$9 Drug Could Potentially Save Thousands
A recently published Lancet study discussed the effects of tranexamic acid, or TXA, and its potential life saving ability for accident patients. The drug can help stop bleeding in trauma patients, which is good News considering that accidents are the second leading cause of death worldwide, behind AIDS, for those ages 5-45. TXA could be a major breakthrough in saving the lives of the 600,000 people a year who bleed to death.
The drug, which costs about $4.50 per gram (average dose needed for an adult is 2 grams), is considered “One of the cheapest ways ever to save a life” by Ian Roberts, professor of Epidemiology at The London School of Hygiene and Tropical Medicine, and who was also one of the main investigators on the study.
Today, in some affluent countries the drug is used to stop bleeding during elective surgeries, but is not currently approved for use in accident victims. Etienne Krug, Director of Violence and Injury Prevention and Disability at the World Health Organization (WHO) believes that the drug would likely “have the biggest impact in developing countires such as China and India, where 90 percent of injury-related deaths occur.” He continued on to state that, “People often have a fatalistic attitude about accidents and think that nothing can be done to save the person’s life, but this study shows that isn’t true.”
Some doctors are speaking up about their opinions on the drug, including Dr. Karim Brohi, a physician at one of London’s busiest E.R.’s, who believes that TXA is “not just something for developing countries. We could probably use it on a daily basis.”
An application has been submitted to WHO in hopes that TXA will be included on the organizations List of Essential Medicine. The drugs which are named on this list are often used by other organizations, such as UNICEF, when buying drugs for underdeveloped countries.
Prostate Cancer Survival Boosted By Radiation
Study results were given at a recent cancer conference showing that survival is significantly increased for cancer patients whose cancer has spread beyond their prostate if radiation is added along with standard hormone treatments.
This could be a major advance in prostate cancer treatment, as the study has the ability to change the plan of care immediately. The study focused on men whose cancer had spread to areas around the prostate, which make up about 20 percent of the almost 200,000 cases of prostate cancer which are diagnosed in the U.S. each year.
Study leader Dr. Padraig Warde, who is a radiation expert from The University of Toronto’s Princess Margaret Hospital explains that, “It is this group of patients in whom many of the deaths from prostate cancer occur, because the condition is usually incurable.” Last year alone, 192,280 new cases of prostate cancer were diagnosed and 27, 360 of those men died.
The seven year study involved 1,200 men who got either hormones plus radiation or just hormones by themselves. At the conclusion of the study, 66 percent of those receiving only hormones were alive compared to 74 percent of the men who had received both hormones and radiation.
The study, which was sponsored by the National Cancer Institute of Canada, was applauded by American Cancer Society’s Chief Medical Officer, Dr. Brawley, who explained that, “It’s a practice-changing study in certain countries, especially in Europe, where more men are diagnosed with locally advanced tumors than here in the U.S.”